Cardax, Inc. (CDXI) financial statements (2020 and earlier)

Company profile

Business Address 2800 WOODLAWN DRIVE
HONOLULU, HI 96822
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0020000
Cash and cash equivalents0020000
Receivables000    
Inventory, net of allowances, customer advances and progress billings1100 11
Inventory1100 11
Prepaid expense0000000
Deposits current assets0000000
Total current assets:2230011
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment  00000
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Total noncurrent assets:0000000
TOTAL ASSETS:2231122
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2211111
Accounts payable     11
Accrued liabilities      1
Employee-related liabilities0000000
Other undisclosed accounts payable and accrued liabilities12111  
Debt1     9
Due to related parties0000000
Other liabilities     00
Other undisclosed current liabilities6344444
Total current liabilities:86555515
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt10     
Accounts payable and accrued liabilities00     
Due to related parties1      
Other undisclosed noncurrent liabilities      0
Total noncurrent liabilities:10    0
Total liabilities:96555515
Stockholders' equity
Stockholders' equity attributable to parent, including:(7)(4)(1)(4)(4)(3)(13)
Common stock0000000
Additional paid in capital60585652504720
Deferred compensation equity  (0)  (0) 
Accumulated deficit(67)(62)(58)(56)(54)(50) 
Other undisclosed stockholders' equity attributable to parent      (33)
Total stockholders' equity:(7)(4)(1)(4)(4)(3)(13)
TOTAL LIABILITIES AND EQUITY:2231122

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues12100  
Other income 00 0
Cost of revenue
(Cost of Goods and Services Sold)
(0)(1)(0)(0)(0)(0)(0)
Gross profit:01000(0)(0)
Operating expenses(4)(5)(2)(2)(4)(17)(4)
Other undisclosed operating income (loss)    (0)0(1)
Operating loss:(4)(4)(2)(2)(4)(17)(4)
Nonoperating income (expense)(1)(0)000(0)(1)
Investment income, nonoperating 00000 
Debt instrument, convertible, beneficial conversion feature0      
Other nonoperating income (expense)   0  (0)
Interest and debt expense(1)(0)(0)(0)(0)(0)(1)
Loss from continuing operations before equity method investments, income taxes:(6)(4)(2)(2)(4)(17)(6)
Other undisclosed income from continuing operations before income taxes1000001
Net loss available to common stockholders, basic:(5)(4)(2)(2)(4)(17)(4)
Other undisclosed net loss available to common stockholders, diluted(0)      
Net loss available to common stockholders, diluted:(5)(4)(2)(2)(4)(17)(4)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(5)(4)(2)(2)(4)(17)(4)
Comprehensive loss, net of tax, attributable to parent:(5)(4)(2)(2)(4)(17)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: